VG 101 - Bionovo

Drug Profile

VG 101 - Bionovo

Alternative Names: Seala; VG101

Latest Information Update: 12 Mar 2012

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Bionovo
  • Class
  • Mechanism of Action Selective estrogen receptor beta modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Atrophic vaginitis

Most Recent Events

  • 12 Mar 2012 No development reported - Preclinical for Vaginal atrophy in USA (Vaginal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top